We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT01615328
First Posted: June 8, 2012
Last Update Posted: July 23, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Jin S. Yeom, Seoul National University Hospital
  Purpose

Anterior cervical discectomy and fusion (ACDF) has shown good treatment results for a variety of cervical spine diseases such as herniated intervertebral disc (HIVD), cervical spondylotic radiculopathy (CSR) and cervical spondylotic myelopathy (CSM). ACDF using autogenous iliac bone graft is gold standard, however, it may lead to donor-site morbidities. Preventing these complications, some authors have tried to use alterative bone graft substitutes. Among these alternatives, Cervios ChronOs™ which is the polyetheretherketone (PEEK) cage with b-tricalcium phosphate (TCP) has become popular and shown good clinical results. However, b-TCP has only osteoconduction ability of three osteogenic properties.

Recently, Bonion™ which is the PEEK cage filled with hydroxyapatite (HA) / demineralized bone matrix (DBM) is introduced. HA/DBM mixture has abilities of osteoconduction and osteoinduction, therefore this alternative is expected to show superior bone fusion capability to PEEK cage with b-TCP. However, there has been no comparison study between the PEEK cage with b-TCP and the PEEK cage with HA/DBM. The purpose of this study is to evaluate bone fusion rate between these cervical spine cages using postoperative computed tomography (CT)


Condition Intervention Phase
Intervertebral Disk Degeneration Intervertebral Disk Displacement Ossification of Posterior Longitudinal Ligament Device: Cervios ChronOs Device: Bonion Phase 4

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: Evaluation of Fusion Rate of Anterior Cervical Discectomy and Fusion (ACDF) Using Cervios ChronOs™ and Bonion™

Resource links provided by NLM:


Further study details as provided by Jin S. Yeom, Seoul National University Hospital:

Primary Outcome Measures:
  • Bone Fusion With CT(Postoperative 6 Months) [ Time Frame: 6 months after surgery(ACDF) ]
    Evaluation of bone fusion between bone substitutes and cervical vertebral endplates with 3-dimensional CT at 6 months after operation (ACDF).


Secondary Outcome Measures:
  • VAS of Radiating Pain (Postoperative 6 Months) [ Time Frame: at 6 months after surgery (ACDF) ]

    Evaluation of radiating pain using the visual analogue scale (VAS) at 6 months after operation (ACDF).

    Reported pain using VAS was recorded and evaluated. Patients were instructed to make a mark on a horizontally-oriented, 10-point VAS labeled "no pain (zero point)" at the far left and "greatest pain (ten point)" at the far right.


  • VAS of Neck Pain(Postoperative 6 Months) [ Time Frame: at 6 months after surgery (ACDF) ]

    Evaluation of neck pain using the visual analogue scale (VAS) at 6 months after operation (ACDF).

    Reported pain using VAS was recorded and evaluated. Patients were instructed to make a mark on a horizontally-oriented, 10-point VAS labeled "no pain (zero point)" at the far left and "greatest pain (ten point)" at the far right.



Enrollment: 85
Study Start Date: November 2011
Study Completion Date: August 2013
Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Cervios ChronOs
The ACDF surgery will be carried out with Cervios ChronOs(TM), which is the PEEK cage filled with b-TCP.
Device: Cervios ChronOs
The ACDF surgery will be carried out with Cervios ChronOs after randomization procedure.
Experimental: Bonion
The ACDF surgery will be carried out with Bonion(TM), which is the PEEK cage with HA/DBM.
Device: Bonion
The ACDF surgery will be carried out with Bonion after randomization procedure.

Detailed Description:
Biologically, graft material should be endowed with several basic properties. Several synthetic materials and graft substitutes have been developed to maximize fusion outcomes while avoiding complications of harvesting autograft. Mixture of hydroxyapatite (HA) and β-tricalcium phosphate (β-TCP), have been widely utilized for bony regeneration. On the other hand, demineralized bone matrix (DBM) has been utilized as a graft substitute with mainly its osteoinductive ability. While HA and β-TCP have osteoinductive osteoconductive properties and DBM has osteoconductive osteoinductive properties, a graft material fully incorporating both properties has not been developed. We hypothesize that an interbody graft material equipped simultaneously with osteoinductivity and osteoconductivity would enhance fusion achievement; however, clinical trials with mixture materials within a PEEK cage in ACDF surgery have rarely been performed.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   20 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of cervical HIVD, CSR, CSM or OPLL
  • The patient who is expected to receive anterior cervical discectomy and fusion operation.
  • Volunteer for this study with written consent.

Exclusion Criteria:

  • Patient with cervical spine fracture, infection.
  • Below -3.5 T-score by DEXA bone densitometry
  • Patient with hemorrhagic diseases
  • Patient with malignancy
  • Patient who is not suitable for this study judged by principal investigator
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01615328


Locations
Korea, Republic of
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, Korea, Republic of, 463-707
Sponsors and Collaborators
Seoul National University Hospital
Investigators
Principal Investigator: Jin Sup Yeom, MD, PhD Seoul National Univerity Hospital
  More Information

Responsible Party: Jin S. Yeom, Associate Professor, Seoul National University Hospital
ClinicalTrials.gov Identifier: NCT01615328     History of Changes
Other Study ID Numbers: Bonion ACDF
First Submitted: June 6, 2012
First Posted: June 8, 2012
Results First Submitted: September 15, 2013
Results First Posted: November 18, 2013
Last Update Posted: July 23, 2014
Last Verified: July 2014

Keywords provided by Jin S. Yeom, Seoul National University Hospital:
anterior cervical discectomy and fusion
bone graft substitute
PEEK cage
hydroxyapatite
demineralized bone matrix
b-tricalcium phosphate
Bonion
Cervios ChronOs

Additional relevant MeSH terms:
Intervertebral Disc Degeneration
Intervertebral Disc Displacement
Ossification of Posterior Longitudinal Ligament
Spinal Diseases
Bone Diseases
Musculoskeletal Diseases
Hernia
Pathological Conditions, Anatomical
Ossification, Heterotopic
Pathologic Processes